tiprankstipranks
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
Holding DNTH?
Track your performance easily

Dianthus Therapeutics (DNTH) Income Statement

305 Followers

Dianthus Therapeutics Income Statement

Last quarter (Q3 2024), Dianthus Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Dianthus Therapeutics's net income was $-25.17M. See Dianthus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.30M$ 2.83M$ 6.42M---
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 69.67M$ 51.00M$ 36.12M$ 74.69M$ 78.70M$ 82.97M
Operating Income
$ -62.86M$ -48.17M$ -29.70M$ -74.69M$ -78.70M$ -82.97M
Net Non Operating Interest Income Expense
$ 10.06M$ 4.76M$ -1.15M$ 3.56M$ 3.77M$ 6.20M
Other Income Expense
$ -5.05M$ -145.00K$ 84.00K$ -45.11M$ -51.18M-
Pretax Income
$ -80.16M$ -43.55M$ -28.48M$ -71.14M$ -74.94M$ -76.77M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -76.81M$ -43.55M$ -28.48M$ -13.11M$ -74.94M$ -76.77M
Basic EPS
$ 14.37$ -8.45$ -20.64$ -20.64$ -27.36-
Diluted EPS
$ 14.37$ -8.45$ -20.64$ -20.64$ -27.36$ -33.12
Basic Average Shares
$ 103.26M$ 5.15M$ 3.71M$ 3.43M$ 2.75M$ 2.31M
Diluted Average Shares
$ 103.26M$ 5.15M$ 3.71M$ 3.43M$ 2.75M$ 2.31M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 69.67M$ 51.00M$ 36.12M$ 74.69M$ 78.70M$ 82.97M
Net Income From Continuing And Discontinued Operation
$ -74.95M$ -43.55M$ -28.48M$ -13.11M$ -74.94M$ -76.77M
Normalized Income
$ -74.27M$ -36.64M-$ -56.20M--
Interest Expense
------
EBIT
$ -73.58M$ -48.17M$ -29.70M$ -13.09M$ -74.94M$ -76.77M
EBITDA
$ -72.63M$ -47.82M$ -29.56M$ -13.09M$ -72.96M$ -74.93M
Currency in USD

Dianthus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis